{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:46:52Z","timestamp":1772578012931,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2017SZ0094"],"award-info":[{"award-number":["2017SZ0094"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2017SZ0108"],"award-info":[{"award-number":["2017SZ0108"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijoms.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijom.2019.07.016","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:24:46Z","timestamp":1566433486000},"page":"298-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"49","author":[{"given":"Z.","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Que","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2019.07.016_bib0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S8756-3282(01)00412-4","article-title":"Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro","volume":"28","author":"Benford","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2019.07.016_bib0010","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.07.016_bib0015","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1006\/bbrc.1999.1849","article-title":"Mechanism of aminobisphosphonate action: characterization of alendronate inhibition of the isoprenoid pathway","volume":"266","author":"Keller","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijom.2019.07.016_bib0020","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.07.016_bib0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijom.2019.07.016_bib0030","first-page":"2035","article-title":"RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?","volume":"19","author":"Van den Wyngaert","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijom.2019.07.016_bib0035","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijom.2019.07.016_bib0040","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.07.016_bib0045","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2019.07.016_bib0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2019.07.016_bib0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1479-5876-9-135","article-title":"Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study","volume":"9","author":"Stockmann","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijom.2019.07.016_bib0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1601-0825.2010.01778.x","article-title":"Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment","volume":"17","author":"Wehrhan","year":"2011","journal-title":"Oral Dis"},{"key":"10.1016\/j.ijom.2019.07.016_bib0065","first-page":"5","article-title":"Angiogenesis in the development of medication-related osteonecrosis of the jaws: an overview","author":"Pabst","year":"2016","journal-title":"Dent J"},{"key":"10.1016\/j.ijom.2019.07.016_bib0070","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijom.2019.07.016_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cpt.597","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijom.2019.07.016_bib0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cpt.1409","article-title":"Clinical Pharmacogenetics Implementation Consortium guideline for cytochrome P450 (CYP)2D6 genotype and atomoxetine therapy","volume":"106","author":"Brown","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijom.2019.07.016_bib0085","first-page":"579","article-title":"A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer","volume":"6","author":"English","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ijom.2019.07.016_bib0090","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3324\/haematol.2011.042572","article-title":"CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma","volume":"96","author":"Such","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.ijom.2019.07.016_bib0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2362.2009.02125.x","article-title":"STrengthening the REporting of Genetic Association studies (STREGA)\u2014an extension of the STROBE statement","volume":"39","author":"Little","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ijom.2019.07.016_bib0100","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ijom.2019.07.016_bib0105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0714.2010.01004.x","article-title":"Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws","volume":"40","author":"Arduino","year":"2011","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ijom.2019.07.016_bib0110","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1601-0825.2012.01912.x","article-title":"New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw","volume":"18","author":"Balla","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.ijom.2019.07.016_bib0115","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.2011.08622.x","article-title":"A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling","volume":"154","author":"Di Martino","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijom.2019.07.016_bib0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijom.2011.02.002","article-title":"Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw","volume":"40","author":"Katz","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.07.016_bib0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/bmm.12.14","article-title":"An aromatase polymorphism (g.132810C&T) predicts risk of bisphosphonate-related osteonecrosis of the jaw","volume":"6","author":"La Ferla","year":"2012","journal-title":"Biomark Med"},{"key":"10.1016\/j.ijom.2019.07.016_bib0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","article-title":"Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3","volume":"17","author":"Nicoletti","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.ijom.2019.07.016_bib0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcms.2012.10.018","article-title":"Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw","volume":"41","author":"Stockmann","year":"2013","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.ijom.2019.07.016_bib0140","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/odi.12355","article-title":"Genetic association between VEGF polymorphisms and BRONJ in the Korean population","volume":"21","author":"Choi","year":"2015","journal-title":"Oral Dis"},{"key":"10.1016\/j.ijom.2019.07.016_bib0145","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1080\/10428194.2017.1300889","article-title":"Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy","volume":"58","author":"Kastritis","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijom.2019.07.016_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jbmr.3285","article-title":"SIRT1\/HERC4 locus associated with bisphosphonate-induced osteonecrosis of the jaw: an exome-wide association analysis","volume":"33","author":"Yang","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2019.07.016_bib0155","first-page":"364","article-title":"Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw","volume":"3","author":"Marini","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.ijom.2019.07.016_bib0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000342120","article-title":"Association between CYP2C8 (rs1934951) polymorphism and bisphosphonate-related osteonecrosis of the jaws in patients on bisphosphonate therapy: a meta-analysis","volume":"129","author":"Zhong","year":"2013","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ijom.2019.07.016_bib0165","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.coms.2015.06.005","article-title":"Pharmacogenetics of bisphosphonate-associated osteonecrosis of the jaw","volume":"27","author":"Fung","year":"2015","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.ijom.2019.07.016_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijom.2019.04.014","article-title":"Genetic predisposition for medication-related osteonecrosis of the jaws: a systematic review","author":"Sandro Pereira da Silva","year":"2019","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.07.016_bib0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/pr.115.011411","article-title":"Role of cytochrome P450 2C8 in drug metabolism and interactions","volume":"68","author":"Backman","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ijom.2019.07.016_bib0180","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/dmd.118.081539","article-title":"Complete substrate inhibition of cytochrome P450 2C8 by AZD9496, an oral selective estrogen receptor degrader","volume":"46","author":"Bapiro","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ijom.2019.07.016_bib0185","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tem.2010.08.006","article-title":"PPAR\u03b3 in bone homeostasis","volume":"21","author":"Wan","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ijom.2019.07.016_bib0190","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1359\/jbmr.080419","article-title":"PPARG by dietary fat interaction influences bone mass in mice and humans","volume":"23","author":"Ackert-Bicknell","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2019.07.016_bib0195","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/diabetes.51.5.1635","article-title":"A common polymorphism in the 5\u2032-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes","volume":"51","author":"Awata","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ijom.2019.07.016_bib0200","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cyto.2009.03.012","article-title":"Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis","volume":"46","author":"Costa","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.ijom.2019.07.016_bib0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000054076","article-title":"A common 936 C\/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels","volume":"37","author":"Renner","year":"2000","journal-title":"J Vasc Res"},{"key":"10.1016\/j.ijom.2019.07.016_bib0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.joca.2007.06.017","article-title":"Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population","volume":"16","author":"Kim","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ijom.2019.07.016_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044552","article-title":"Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis","volume":"7","author":"Tyagi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijom.2019.07.016_bib0220","doi-asserted-by":"crossref","first-page":"C162","DOI":"10.1152\/ajpcell.00014.2017","article-title":"Estradiol activates chloride channels via estrogen receptor-alpha in the cell membranes of osteoblasts","volume":"313","author":"Deng","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ijom.2019.07.016_bib0225","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/jbmr.1788","article-title":"Gene\u2013gene interaction between RBMS3 and ZNF516 influences bone mineral density","volume":"28","author":"Yang","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2019.07.016_bib0230","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jmb.2007.06.006","article-title":"RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1","volume":"371","author":"Fritz","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijom.2019.07.016_bib0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","article-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data","volume":"67","author":"Allen","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2019.07.016_bib0240","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bone.2003.07.007","article-title":"Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates","volume":"33","author":"van Beek","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2019.07.016_bib0245","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1185\/03007990802352894","article-title":"Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis","volume":"24","author":"Marini","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijom.2019.07.016_bib0250","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jcp.20329","article-title":"Organization of transcriptional regulatory machinery in osteoclast nuclei: compartmentalization of Runx1","volume":"204","author":"Saltman","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ijom.2019.07.016_bib0255","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jbmr.1824","article-title":"Silent information regulator (Sir)T1 inhibits NF-kappaB signaling to maintain normal skeletal remodeling","volume":"28","author":"Edwards","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ijom.2019.07.016_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185236","article-title":"SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis","volume":"12","author":"Zainabadi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijom.2019.07.016_bib0265","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1182\/blood-2015-07-658203","article-title":"The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ijom.2019.07.016_bib0270","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2188\/jea.JE20150173","article-title":"Evaluation of the endorsement of the STrengthening the REporting of Genetic Association Studies (STREGA) Statement on the reporting quality of published genetic association studies","volume":"26","author":"Nedovic","year":"2016","journal-title":"J Epidemiol"},{"key":"10.1016\/j.ijom.2019.07.016_bib0275","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1524-4741.2011.01119.x","article-title":"Osteonecrosis of the jaw in patients with metastatic breast cancer: ethnic and socio-economic aspects","volume":"17","author":"Quispe","year":"2011","journal-title":"Breast J"},{"key":"10.1016\/j.ijom.2019.07.016_bib0280","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502719312676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502719312676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:31:28Z","timestamp":1760272288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502719312676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0901502719312676"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2019.07.016","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijom.2019.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}